Perioperative Hyperglycaemia in Primary Total Hip and Knee Replacement (HyTe-1)
Determinants of Perioperative Hyperglycaemia in Primary Hip and Knee Replacement
Sponsor: Coxa, Hospital for Joint Replacement
Listed as NCT01021826, this observational or N/A phase trial focuses on Hip Replacement and Hyperglycemia and remains completed. Sponsored by Coxa, Hospital for Joint Replacement, it has been updated 11 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Apr 2019 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Apr 2019 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Dec 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Coxa, Hospital for Joint Replacement
- Tampere University
For direct contact, visit the study record on ClinicalTrials.gov .